Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.4656
-0.0094 (-1.98%)
At close: Nov 14, 2025, 4:00 PM EST
0.4880
+0.0224 (4.81%)
After-hours: Nov 14, 2025, 7:58 PM EST
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $32.75 million as of November 14, 2025. Its market cap has increased by 272.76% in one year.
Market Cap
32.75M
Enterprise Value
25.40M
1-Year Change
272.76%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $32.75M, a decrease of -74.28%. That is a compound annual growth rate of -31.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 32.75M | 217.55% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.86B |
| Johnson & Johnson | 470.41B |
| AbbVie | 410.55B |
| UnitedHealth Group | 301.21B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.65B |
| Abbott Laboratories | 224.77B |